Salts 668

Details for Australian Patent Application No. 2008212714 (hide)

Owner AstraZeneca AB

Inventors Whittock, Robert; Withnall, Jane

Agent Freehills

Pub. Number AU-A-2008212714

PCT Pub. Number WO2008/096112

Priority 0702458.1 08.02.07 GB

Filing date 6 February 2008

Wipo publication date 14 August 2008

International Classifications

C07D 277/68 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

13 August 2009 PCT application entered the National Phase

  PCT publication WO2008/096112 Priority application(s): WO2008/096112

30 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008212718-Wire termination device

2008212713-Combinations of beta2 -adrenoceptor agonistic benzothiazolone